News Release

September 8 , 2006 -- BCF Delivers Fairness Opinion in HealthpointCapital's Acquisition of BioLok

Boston, MA – Boston Corporate Finance, Inc. (BCF), a member of M&A International, Inc., announced today that it rendered a fairness opinion to the Board of Directors of BioLok International Inc. with respect to the sale of BioLok to HealthpointCapital.

BioLok International Inc. (“BioLok”) (OTCBB: BLLI), the manufacturer and worldwide distributor of leading-edge dental implant technology, and HealthpointCapital Partners II, L.P. (“HealthpointCapital”), a private equity firm focused on the orthopedic and musculoskeletal industries, announced that the boards of directors of both companies have unanimously approved a definitive agreement whereby HealthpointCapital will acquire BioLok for $2.15 per share in cash, for a total of approximately $35 million. The definitive agreement requires HealthpointCapital to commence a tender offer for all of BioLok's common shares within five business days, and upon successful completion of that tender offer to complete the acquisition through a merger between BioLok and a HealthpointCapital subsidiary. Holders of a majority of BioLok's shares have already agreed to tender their shares. The acquisition is expected to be completed by November 2006 and is subject to customary closing conditions.

“We have been successfully building our presence in the dental market, which is one of the fastest growing sectors in the medical technology industry,” stated Mortimer Berkowitz III, President and Managing Director of HealthpointCapital. “The addition of BioLok represents a key point of our technology-driven strategy in the dental implant industry. As BioLok has been experiencing growth which is well in excess of the dental implant sector generally, we are very pleased to have the entire BioLok team remain with the company to continue executing on the growth strategy that has been impeccably implemented for the past several years toward becoming a recognized and respected global brand. Our mission is to continue unabated their passion for excellence in the development and commercialization of high quality dental products and servicing of dental practitioners.”

“We believe HealthpointCapital offers both an appealing exit strategy for our shareholders and a springboard to a more promising future for BioLok,” stated Bruce L. Hollander, BioLok's Chairman, President and Chief Executive Officer. “On behalf of the Board, I would like to express our appreciation for the support of our fellow shareholders and the efforts of our employees that were necessary to position BioLok where it is today – as a coveted and major player in the dental implant market. We anticipate that BioLok's acquisition by HealthpointCapital will provide BioLok with substantial resources to compete more effectively on a global scale.”

Miami-based Capitalink, L.C. acted as financial advisor to BioLok.

About Boston Corporate Finance, Inc.

Boston Corporate Finance, Inc. (BCF) is a technology focused investment banking firm serving industry leading companies in the global middle market.  The firm is unique in its technology industry intelligence, deal experience and global reach.  The transaction experts at BCF deliver an array of investment banking services with a focus on mergers and acquisitions and private placements of debt and equity.  For more information, please visit www.bostoncf.com or call (781) 320-3200.

Boston Corporate Finance, Inc.
200 Lowder Brook Drive, Suite 2600
Westwood, MA 02090

Tel: (781) 320-3200
Fax: (781) 320-3220
E-mail: info@bostoncf.com

View this press release in PDF format.